Aprea Therapeutics APRE
€ 2.77
1.13%
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Aprea Therapeutics Bilanz 2011-2024 | APRE
Bilanz Jährlich Aprea Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | - | - | -130 M | -65.7 M | -24.4 M | - | - | - | - | - | - |
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
- | - | - | 256 K | 242 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 303 K | 113 M | 56.2 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
4.39 M | 3.2 M | 7.32 M | 15.3 M | 9.06 M | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | 15.4 M | 9.36 M | 117 M | 60.5 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
529 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-308 M | -294 M | -181 M | -144 M | -90.5 M | -62.5 M | -46.9 M | - | - | - | - | - | - |
Vermögenswerte |
22.7 M | 30.2 M | 56.8 M | 92.8 M | 134 M | 66 M | 24.8 M | - | - | - | - | - | - |
Zahlungsmittel |
21.6 M | 28.8 M | 53.1 M | 89 M | 130 M | 65.7 M | 24.4 M | - | - | - | - | - | - |
Buchwert |
22.7 M | 30.2 M | 56.8 M | 77.4 M | 124 M | -51.4 M | -35.8 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
17 M | 25.6 M | 49.5 M | 77.4 M | 124 M | -51.4 M | -35.8 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Aprea Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | 28.1 K | - | 29.8 K | - | 33.8 K | 78.8 K | 78.8 K | 78.8 K | 78.8 K | 303 K | 303 K | 303 K | 303 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | - | - | 3.95 M | 4.23 M | 3.2 M | 4 M | 7.68 M | 6.75 M | 7.32 M | 9.07 M | 10.6 M | 11.2 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 9.36 M | 9.36 M | 9.36 M | 9.36 M | 4.87 M | 4.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | 50.7 K | 148 K | 529 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-318 M | -314 M | -311 M | -308 M | -305 M | -301 M | -298 M | -294 M | -291 M | -287 M | -189 M | -181 M | -173 M | -164 M | -154 M | -144 M | -144 M | -144 M | -144 M | -90.5 M | -90.5 M | -90.5 M | -90.5 M | -62.5 M | -62.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
26.9 M | 30 M | 33.2 M | 22.7 M | 25.8 M | 28.7 M | 32 M | 30.2 M | 33.6 M | 40.7 M | 50.3 M | 56.8 M | 62.5 M | 71.5 M | 80.4 M | 92.8 M | 92.8 M | 92.8 M | 92.8 M | 134 M | 134 M | 134 M | 134 M | 66 M | 66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
26.2 M | 28.7 M | 32.4 M | 21.6 M | 25.4 M | 27.7 M | 31 M | 28.8 M | 33.1 M | 39.1 M | 47.7 M | 53.1 M | 61.4 M | 69.8 M | 77.6 M | 89 M | 89 M | 89 M | 89 M | 130 M | 130 M | 130 M | 130 M | 65.7 M | 65.7 M | - | - | 24.4 M | - | - | - | 13.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
- | - | - | - | - | 24.7 M | 27.8 M | 27 M | 29.6 M | 33 M | 43.6 M | 49.5 M | 53.4 M | 61 M | 69.1 M | 77.4 M | 77.4 M | 77.4 M | 77.4 M | 124 M | 124 M | 124 M | 124 M | 61.2 M | 61.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
21.9 M | 25.6 M | 28.9 M | 17 M | 20.3 M | 23.4 M | 26.5 M | 25.6 M | 26.6 M | -35.8 M | 43.6 M | 49.5 M | 53.4 M | 61 M | 69.1 M | 77.4 M | 77.4 M | 77.4 M | 77.4 M | 124 M | 124 M | 124 M | 124 M | -51.4 M | -51.4 M | -44.5 M | - | -35.8 M | - | - | - | -21.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung